The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

Clinical trial NCT00215800 · COMPLETED

Trial details

NCT number: NCT00215800
Sponsor: AIM ImmunoTech Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Fatigue Syndrome Myalgic Encephalomyelitis

Start date: 1998-12-01
Primary completion: 2004-02-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.